PCSA Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. (PCSA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: July 1, 2026 , by Ng George K .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer | Buy | 3,057 | $1.93 | $5.9K | 15,492 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 3,277 | $1.93 | $6.3K | 16,689 | |
| Young David | Pres. Research & Development | Buy | 2,531 | $1.93 | $4.9K | 21,729 | |
| Guy Wendy | Chief Administrative Officer | Buy | 2,436 | $1.93 | $4.7K | 14,394 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 2,106 | $1.93 | $4.1K | 13,113 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 2,654 | $2.22 | $5.9K | 13,412 | |
| Ng George K | Chief Executive Officer | Buy | 2,465 | $2.22 | $5.5K | 12,435 | |
| Guy Wendy | Chief Administrative Officer | Buy | 2,118 | $2.22 | $4.7K | 11,958 | |
| Young David | Pres. Research & Development | Buy | 2,067 | $2.22 | $4.6K | 19,198 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 1,831 | $2.22 | $4.1K | 11,007 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 2,292 | $2.57 | $5.9K | 10,758 | |
| Ng George K | Chief Executive Officer | Buy | 2,129 | $2.57 | $5.5K | 9,970 | |
| Guy Wendy | Chief Administrative Officer | Buy | 1,829 | $2.57 | $4.7K | 9,840 | |
| Young David | Pres. Research & Development | Buy | 1,786 | $2.57 | $4.6K | 17,131 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 1,582 | $2.57 | $4.1K | 9,176 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 1,984 | $2.97 | $5.9K | 8,466 | |
| Ng George K | Chief Executive Officer | Buy | 1,843 | $2.97 | $5.5K | 7,841 | |
| Guy Wendy | Chief Administrative Officer | Buy | 1,583 | $2.97 | $4.7K | 8,011 | |
| Young David | Pres. Research & Development | Buy | 1,545 | $2.97 | $4.6K | 15,345 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 1,369 | $2.97 | $4.1K | 7,594 | |
| Bigora Sian 2 fills | Chief Development Officer | Buy | 3,957 | $2.70 | $10.7K | 7,496 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 2,190 | $2.69 | $5.9K | 6,498 | |
| Ng George K | Chief Executive Officer | Buy | 2,034 | $2.69 | $5.5K | 6,013 | |
| Guy Wendy | Chief Administrative Officer | Buy | 1,748 | $2.69 | $4.7K | 6,441 | |
| Young David | Pres. Research & Development | Buy | 1,706 | $2.69 | $4.6K | 13,813 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 1,511 | $2.69 | $4.1K | 6,236 | |
| Ng George K 3 fills | Chief Executive Officer | Buy | 5,529 | $2.97 | $16.4K | 5,492 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 1,984 | $2.97 | $5.9K | 4,308 | |
| Bigora Sian | Chief Development Officer | Buy | 1,799 | $2.97 | $5.3K | 5,510 | |
| Guy Wendy | Chief Administrative Officer | Buy | 1,583 | $2.97 | $4.7K | 4,693 | |
| Young David | Pres. Research & Development | Buy | 1,545 | $2.97 | $4.6K | 12,107 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 1,369 | $2.97 | $4.1K | 4,725 | |
| Ng George K 2 fills | Chief Executive Officer | Buy | 4,272 | $2.54 | $10.8K | 3,649 | |
| SKIBSTED RUSSELL | Chief Financial Officer | Buy | 2,324 | $2.54 | $5.9K | 2,324 | |
| Baluch Khoso | Director | Buy | 2,269 | $2.54 | $5.8K | 2,325 | |
| Bigora Sian | Chief Development Officer | Buy | 2,107 | $2.54 | $5.3K | 3,711 | |
| Pannu Geraldine | Director | Buy | 2,072 | $2.54 | $5.3K | 2,188 | |
| Guy Wendy | Chief Administrative Officer | Buy | 1,854 | $2.54 | $4.7K | 3,110 | |
| Young David | Pres. Research & Development | Buy | 1,810 | $2.54 | $4.6K | 10,562 | |
| Lin Patrick | Chief Business - Strategy Off | Buy | 1,603 | $2.54 | $4.1K | 3,356 | |
| Neal James R | Director | Buy | 789 | $2.54 | $2.0K | 818 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.